Brokerages expect that IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Rating) will announce sales of $8.50 million for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for IDEAYA Biosciences’ earnings. The lowest sales estimate is $7.00 million and the highest is $10.00 million. IDEAYA Biosciences reported sales of $7.25 million in the […]
Brokerages expect that IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Rating) will announce ($0.41) earnings per share (EPS) for the current quarter, Zacks reports. Four analysts have made estimates for IDEAYA Biosciences’ earnings, with the lowest EPS estimate coming in at ($0.59) and the highest estimate coming in at ($0.17). IDEAYA Biosciences posted earnings per share […]
Brokerages forecast that IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Rating) will post earnings per share of ($0.31) for the current quarter, according to Zacks. Three analysts have issued estimates for IDEAYA Biosciences’ earnings, with estimates ranging from ($0.39) to ($0.17). IDEAYA Biosciences reported earnings per share of ($0.28) during the same quarter last year, which […]
IDEAYA Biosciences (NASDAQ:IDYA – Get Rating) posted its quarterly earnings results on Tuesday. The company reported ($0.47) EPS for the quarter, missing analysts’ consensus estimates of ($0.31) by ($0.16), MarketWatch Earnings reports. IDEAYA Biosciences had a negative return on equity of 14.83% and a negative net margin of 103.19%. During the same quarter in the […]
California State Teachers Retirement System trimmed its stake in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Rating) by 54.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 17,700 shares of the company’s stock after selling 20,994 shares […]